Medication use among pregnant women from the 2015 Pelotas (Brazil) birth cohort study
dc.contributor.author | Lutz, Bárbara Heather | pt_BR |
dc.contributor.author | Miranda, Vanessa Iribarrem Avena | pt_BR |
dc.contributor.author | Silveira, Marysabel Pinto Telis | pt_BR |
dc.contributor.author | Dal Pizzol, Tatiane da Silva | pt_BR |
dc.contributor.author | Mengue, Sotero Serrate | pt_BR |
dc.contributor.author | Silveira, Mariângela Freitas da | pt_BR |
dc.contributor.author | Domingues, Marlos Rodrigues | pt_BR |
dc.contributor.author | Bertoldi, Andréa Dâmaso | pt_BR |
dc.date.accessioned | 2020-06-25T03:33:08Z | pt_BR |
dc.date.issued | 2020 | pt_BR |
dc.identifier.issn | 1660-4601 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/210579 | pt_BR |
dc.description.abstract | Background: Medication use during pregnancy is a common practice that has been increasing in recent years. The aim of this study is to describe medication use among pregnant women from the 2015 Pelotas (Brazil) Birth Cohort Study. Methods: This paper relies on a population-based cohort study including 4270 women. Participants completed a questionnaire about the antenatal period, including information about medication use. We performed descriptive analyses of the sample and the medications used and adjusted analyses for the use of medications and self-medication. Results: The prevalence of medication use was 92.5% (95% CI 91.7–93.3), excluding iron salts, folic acid, vitamins, and other minerals. The prevalence of self-medication was 27.7% (95% CI 26.3–29.1). In the adjusted analysis, women who had three or more health problems during pregnancy demonstrated higher use of medicines. Self-medication was higher in lower income groups and among smokers and multiparous women (three pregnancies or more). Acetaminophen, scopolamine, and dimenhydrinate were the medications most commonly used. Conclusions: This study describes the pattern of drug use among pregnant women in a population-based cohort study, with a high prevalence of self-medication. Greater awareness of the risks of self-medication during pregnancy is required, focusing on groups more prone to this practice, as well as ensuring qualified multidisciplinary prenatal care. | en |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | International journal of environmental research and public health. Basel. Vol. 17, n. 3 (2020), 989, [14 p.] | pt_BR |
dc.rights | Open Access | en |
dc.subject | Drug use | en |
dc.subject | Uso de medicamentos | pt_BR |
dc.subject | Preparações farmacêuticas | pt_BR |
dc.subject | Drug utilization | en |
dc.subject | Pharmaceutical preparations | en |
dc.subject | Farmacoepidemiologia | pt_BR |
dc.subject | Self-medication | en |
dc.subject | Estudos de coortes | pt_BR |
dc.subject | Farmácia | pt_BR |
dc.subject | Pharmacoepidemiology | en |
dc.subject | Pregnancy | en |
dc.subject | Gravidez | pt_BR |
dc.subject | Cohort studies | en |
dc.title | Medication use among pregnant women from the 2015 Pelotas (Brazil) birth cohort study | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 001114204 | pt_BR |
dc.type.origin | Estrangeiro | pt_BR |
Este item está licenciado na Creative Commons License
-
Artigos de Periódicos (39708)Ciências da Saúde (10620)